Get the Stockscreener App
438.10
0.39%
-1.70
After Hours:
437.33
-0.77
-0.18%
Intuitive Surgical Inc stock is traded at $438.10, with a volume of 2.00M.
It is down -0.39% in the last 24 hours and down -9.41% over the past month.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$439.80
Open:
$439.495
24h Volume:
2.00M
Relative Volume:
1.02
Market Cap:
$155.16B
Revenue:
$10.58B
Net Income/Loss:
$3.00B
P/E Ratio:
53.14
EPS:
8.2437
Net Cash Flow:
$2.83B
1W Performance:
+4.03%
1M Performance:
-9.41%
6M Performance:
-21.99%
1Y Performance:
-19.27%
1-Day Range:
$434.77
$443.86
1-Week Range:
$421.95
$449.77
52-Week Range:
$417.74
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Upgrade | Citigroup | Neutral → Buy |
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Intuitive Surgical, Inc. stock (US46120E6023): Da Vinci maker grows on strong procedure demand - AD HOC NEWS
Insider Sell Alert: Mark Brosius Sells Shares of Intuitive Surgi - GuruFocus
Intuitive surgical EVP Mark Brosius sells $15,945 in stock By Investing.com - Investing.com South Africa
Intuitive surgical EVP Mark Brosius sells $15,945 in stock - Investing.com
Intuitive Surgical (ISRG) EVP Brosius sells 36 shares in planned trades - Stock Titan
Intuitive readies 100 updates and improvements for da Vinci 5 - MedTech Dive
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical - TradingView
3 Big Reasons ISRG Should Be On Your Watchlist - Yahoo Finance
Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors - Yahoo Finance
Are Wall Street Analysts Bullish on Intuitive Surgical Stock? - Yahoo Finance
Precision Trading with Intuitive Surgical Inc. (ISRG) Risk Zones - Stock Traders Daily
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - MarketWatch
2 Most Compelling Stocks to Buy for Long‑Term Investors Right Now - The Motley Fool
Intuitive Surgical stock (US46120E6023): insider sale and long?term growth story in focus - AD HOC NEWS
Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report? - Yahoo Finance
Intuitive Unveils Da Vinci 5 Ecosystem Enhancements - Medical Product Outsourcing
Intuitive announces da Vinci 5 updates, extended instrument use By Investing.com - Investing.com Canada
Intuitive Announces Innovations to Advance Quintuple Aim - Scott Coop
Robotic surgery gets telepresence, force-sensing tools in Intuitive upgrade - Stock Titan
ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver? - TradingView
Insider Sell: Mark Brosius Sells Shares of Intuitive Surgical In - GuruFocus
Intuitive surgical EVP Brosius sells $23,463 in company stock - Investing.com
Intuitive Surgical (NASDAQ: ISRG) EVP sells 54 shares via Rule 10b5-1 plan - Stock Titan
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical stock (US46120E6023): da Vinci maker in focus after latest earnings and analyst u - AD HOC NEWS
North America Minimally Invasive Surgery Robot Market Worth US$ - openPR.com
Investors heavily search Intuitive Surgical, Inc. (ISRG): Here is what you need to know - MSN
Silver Economy Investing: Why the Healthcare Giants Are in Focus - TradingView
Robotics expert Brian Miller on product development, AI and what he learned at Intuitive - Medical Design & Outsourcing
Intuitive Surgical stock (US46120E6023): robot-assisted surgery leader in focus after latest quarter - AD HOC NEWS
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know - Yahoo Finance
ISRG DCF Analysis: Intrinsic Value $196 vs Price $440 - GuruFocus
Intuitive Surgical stock (US46120E6023): robot-assisted surgery leader after latest earnings - AD HOC NEWS
Intuitive Surgical Inc (ISRG) Stock Price, Trades & News - GuruFocus
ISRG Stock Price, Quote & Chart | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 4.5% Rally? GF Value Says Undervalued - GuruFocus
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 4.5% R - GuruFocus
Assessing Intuitive Surgical (ISRG) Valuation After The Recent Share Price Pullback - Yahoo Finance
Intuitive Surgical Price Target Cut to $520.00/Share From $650.00 by B of A Securities - Moomoo
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.76% on May 18: A Full Analysis - TradingKey
Here is what to know beyond why Intuitive Surgical, Inc. (ISRG) is a trending stock - MSN
Intuitive Surgical, Inc. Stock 12‑Month Price Target Cut to $577.87, Implies 37% Upside - TradingView
North Dakota State Investment Board Invests $6.93 Million in Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring A Potential 37% Upside - DirectorsTalk Interviews
Gabelli Funds LLC Reduces Stake in Intuitive Surgical, Inc. $ISRG - MarketBeat
ISRG Technical Analysis | Trend, Signals & Chart Patterns | INTUITIVE SURGICAL INC (NASDAQ:ISRG) - ChartMill
Intuitive Surgical, Inc. (ISRG) advances but underperforms market: Key facts - MSN
The Global Price of Progress: The Geography of Robotic Surgery - Yale Global Health Review
Intuitive Surgical's moat is getting stronger -- is this the closest thing to a 'forever' stock? - MSN
Intuitive Surgical: Buy Rating Reiterated on Strong Momentum and New da Vinci 5 Platform; $650 Price Target Maintained - TipRanks
Intuitive Surgical, Inc. (ISRG) rises but trails market: What investors should know - MSN
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):